Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon L Croft

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
European Journal of Medicinal Chemistry|December 4, 2003
Synthesis and in vitro anti-protozoal activity of a series of benzotropolone derivatives incorporating endocyclic hydrazinesHongyu Ren, Shannon Grady, Matthew Banghart, et al.
Phytotherapy Research : PTR|August 31, 2002
In vitro activity of Triclisia patens and some bisbenzylisoquinoline alkaloids against Leishmania donovani and Trypanosoma brucei bruceiMaria del Rayo Camacho, J David Phillipson, Simon L Croft, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 4, 2006
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical useF Javier Pérez-Victoria, María P Sánchez-Cañete, Karin Seifert, et al.
Bioorganic & Medicinal Chemistry|June 10, 2004
Synthesis and antileishmanial activity of novel buparvaquone oxime derivativesAntti Mäntylä, Jarkko Rautio, Tapio Nevalainen, et al.
Journal of Medicinal Chemistry|December 13, 2005
Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfideSeheli Parveen, Mohammed O F Khan, Susan E Austin, et al.
Biomedical Chromatography : BMC|January 22, 2008
Optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of buparvaquone in human and rabbit plasma: application to pharmacokinetic studyGantala Venkatesh, M I A Majid, S Ramanathan, et al.
International Journal of Antimicrobial Agents|July 14, 2007
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivoKarin Seifert, F Javier Pérez-Victoria, Marianne Stettler, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin BMalika Larabi, Vanessa Yardley, Philippe M Loiseau, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 20, 2004
Prediction of anti-plasmodial activity of Artemisia annua extracts: application of 1H NMR spectroscopy and chemometricsNigel J C Bailey, Yulan Wang, Julia Sampson, et al.
Plos Neglected Tropical Diseases|March 2, 2021
Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasisAndrew A Voak, Andy Harris, Jose Miguel Coteron-Lopez, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
European Journal of Medicinal Chemistry|December 4, 2003
Synthesis and in vitro anti-protozoal activity of a series of benzotropolone derivatives incorporating endocyclic hydrazinesHongyu Ren, Shannon Grady, Matthew Banghart, et al.
Phytotherapy Research : PTR|August 31, 2002
In vitro activity of Triclisia patens and some bisbenzylisoquinoline alkaloids against Leishmania donovani and Trypanosoma brucei bruceiMaria del Rayo Camacho, J David Phillipson, Simon L Croft, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 4, 2006
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical useF Javier Pérez-Victoria, María P Sánchez-Cañete, Karin Seifert, et al.
Bioorganic & Medicinal Chemistry|June 10, 2004
Synthesis and antileishmanial activity of novel buparvaquone oxime derivativesAntti Mäntylä, Jarkko Rautio, Tapio Nevalainen, et al.
Journal of Medicinal Chemistry|December 13, 2005
Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfideSeheli Parveen, Mohammed O F Khan, Susan E Austin, et al.
Biomedical Chromatography : BMC|January 22, 2008
Optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of buparvaquone in human and rabbit plasma: application to pharmacokinetic studyGantala Venkatesh, M I A Majid, S Ramanathan, et al.
International Journal of Antimicrobial Agents|July 14, 2007
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivoKarin Seifert, F Javier Pérez-Victoria, Marianne Stettler, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin BMalika Larabi, Vanessa Yardley, Philippe M Loiseau, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 20, 2004
Prediction of anti-plasmodial activity of Artemisia annua extracts: application of 1H NMR spectroscopy and chemometricsNigel J C Bailey, Yulan Wang, Julia Sampson, et al.
Plos Neglected Tropical Diseases|March 2, 2021
Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasisAndrew A Voak, Andy Harris, Jose Miguel Coteron-Lopez, et al.
Pageof 15